text:
1982 Mr Olympia - THE BATTLE OF CHAMPIONS
This historic DVD is a completely different version than any previously offered. It is the hardcore bodybuilding version of the '82 Olympia, now on DVD.
This exciting video covering the greatest physiques in the world, brings you all the drama, blood, sweat and tension of Chris Dickerson's epic victory in the 1982 Mr Olympia contest held in London. Shot on Super 8 sound film.
Although all 16 men are shown, this video concentrates on the top eight champions as they do battle through each of the three rounds of judging and on to the evening show and final presentation.
We take a different view point being that of combat by comparison, showing you the all important side by side judging comparisons and pose downs between these top men as they strive for victory. You can judge and compare your placings of the top men with the opinions of the official judges, and the comments you will hear from the audience.
However, anything can happen during the free posing round and the atmosphere was electric. Highlights for me included the immaculate and totally professional stage presentations of Chris Dickerson and Mohamed Makkawy, the best ever condition, shape and proportion of Samir, the massive and rock hard muscle of Viator, and the sheer size of Bertil Fox.
Tom Platz was huge and in fact the biggest I have ever seen him, and no professional boby builder has more stage charisma than Tom who it seems is a probable winner in the future. His massive legs are still years ahead of those to be found supporting any other body builder. For Tom's many fans, this video has all the Platz footage, both judging and final.
For Zane's fans he had a completely new routine which included his own unique poses he has made famous such as the vacuum and hands over head poses. He almost stole the title from Dickerson and in many people's eyes was a winner.
Al Beckles went into this contest as one of the hot favourites and he too looked absolutely fantastic, as did Lance Dreher. Dreher had probably the biggest arms, in the famous Larry Scott posing style.
However, there can only be one winner, and CHRIS DICKERSON was a well deserving and popular winner in this his final contest. Chris was superb in all areas - symmetry, cuts, presentation, charisma, condition and muscle density. He had it all together on the day in a totally professional manner that showed class, experience and attention to fine detail. A fitting triumph to climax the competitive career of on the the world's greatest body builders. In his victory speech Chris thanked the great Bill Pearl for all the assistance he had given him.
The results of the 1982 Mr. Olympia:
1. Chris Dickerson
2. Frank Zane
3. Casey Viator
4. Samir Bannout
5. Albert Beckles
6. Tom Platz
7. (Tie) Mohamed Makkawy
Bertil Fox
9. Johnny Fuller
10. Jusup Wilcosz
11. Boyer Coe
12. Danny Padilla
13. Jacques Neuville
14. Dennis Tinerino
15. Lance Dreher
16. Roger Walker
Running Time: 65 mins
* Available in NTSC DVD Only (Region Free)
* THIS DVD WILL PLAY ON ANY DUAL SYSTEM NTSC / PAL DVD PLAYER AND TV. Or any PC DVD.

subset: commoncrawl


text: A group of cold case investigators stay at the Carmichael Manor, site of the grisly and unsolved murders of the Carmichael family back in the eighties. After four nights, the group was never heard from again. What is discovered on their footage is even more disturbing than anything found on the Hell House tapes.


text:
Governments are spending hundreds of millions researching cancer genes. Is it all a big waste of time?
7There is a powerful myth, widely believed by cancer patients and their doctors, that soon a greater understanding of genetics will provide the tools to defeat cancer. Unfortunately this optimistic scenario is in serious trouble, yet few are aware of what has been happening.
The data coming out of the latest American genetic screening program, a 500 million dollar project called The Cancer Genome Atlas (TCGA) launched in 2006 – has revealed that the gene changes within the cells of individual tumours are far more complicated and chaotic than anyone had anticipated.


text: A little too edgy to be considered pop metal, Tesla were probably the least pretentious band of the genre. On Psychotic Supper, they focus on understated, bluesy hard rock, with an occasional acoustic guitar thrown in for variety. The result is well worth a listen, and this album contains some of their best material, including the anthemic "Edison's Medicine" and the no-bull "Call It What You Want." "What You Give" is a lovely, tender alternative to the syrupy power ballads that so many hard rock bands indulged in during the late '80s and early '90s. "Song & Emotion," another slow song, is a tribute to the late Steve Clark of Def Leppard. Tesla's favorite themes are evident on songs like "Change in the Weather," "Don't De-Rock Me," and "Freedom Slaves," but "Toke About It" shows that they also retained their sense of humor


text:
Planet Bike's Snack Sack attaches to your top tube to keep your gear within easy reach. It's made of tough material and has a padded, white interior to make it easy to see your things. Its 43 cubic inches of capacity handle all your essentials. It's also got a dual zipper for easy access and reflective piping, too.
Dimensions: 7 x 3.5 x 2 inches
Part Numbers
Option | UPC | MPN | Store SKU |
Black / 43-inch³ | 642016902208 | 9022 | 210000064895 |


text:
Cabrito, Cabrito, Cabrito
Friday Night Lights
At Friday's New Taste of Texas event. House Marinated Sardines with Burrata, Olives, Orange & Almonds on a Crostino from Spiaggia.
A refreshing desesrt course form Uchiko. Lemon Ash Ice – Green Strawberry Consommé, Black Pepper & Arugula Blossom.
From L to R: Me, Jonathan Waxman, Tim Love, Garrett Weber Gale, Marcus Samuelsson & Nathan Followill
A little after-hours dessert party at the gorgeous Hotel St. Cecilia. One of the only times "boutique hotel" isn't synonymous with "cramped room."
Saturday in the Sun (& Dust)
A pre-demo interview with Josh Ozersy from Time Magazine & Matt Rodbard from Food Republic.
Dude, who doesn't love a pre-demo Slurpee?
Beef heart, courtesy of my friends at Whole Foods. Beautiful, no?
Grilled Bolivian Ox Heart. Best cut of meat on the animal, no joke.
Passing around my One-Pot Sticky Chicken Wings.
Tim Love's cabrito & chili taco at Saturday night's Rock Your Taco party.
Christine Grdovic, Gail Simmons & I 'splain our judging process.
Winner Tyson Cole claims his five-stringed prize.
Tim Love, Gail Simmons, Me & Christina Grdovic
Sunday Funday
Cabrito anyone?
Moroccan Goat Liver & Kidney Kebabs with Lemon and Herb Oil
Marcus Samuelsson & I crash Tim's grilling demo.
How much do you love this interactive demo? I'm stealing this idea for next year.


text:
Target started selling Amazon's line of Kindle e-readers two years ago. Head over to Target.com now, though, and you'll discover a wide assortment of e-readers, but not a single Amazon Kindle for sale. Kindles are being taken off the shelves at Target's nearly 1,800 stores as well, as the retailers' battles over "showrooming" and brand alliances heat up.
"Showrooming" occurs when a shopper visits a physical store to scope out merchandise in person, but then ultimately buys the items at a cheaper price—and typically, with free shipping—from an online retailer. The world's biggest online retailer is Amazon, and it's also assumed to be the biggest beneficiary of showrooming.
Amazon, in fact, actively encourages the practice, which is most easily done through the help of smartphone price-check apps—which allow consumers to compare prices at various retail outlets while they're browsing the aisles of a physical store. During last year's winter holiday shopping season, Amazon was described as "evil" and "disgraceful" for offering special discounts to shoppers who used Amazon's Price Check app for showrooming purposes.
(MORE: 7 Smart Bargains from People Who Know Best: Penny-Pinching Experts)
Retailers that are mostly focused on brick-and-mortar such as Target and Toys R Us are the ones with the most to lose due to showrooming, and Target has been one of the most aggressive in battling against the practice. In January, Target executives released a statement to its vendors announcing:
"What we aren't willing to do is let online-only retailers use our brick-and-mortar stores as a showroom for their products and undercut our prices without making investments, as we do, to proudly display your brands."
These words are now being matched with action. Simply put, Target's response to showrooming is this: You undercut our prices and try to steal our customers, and we're not going to sell your products.
(MORE: Today's Value Shopper Heads to Amazon, Not Walmart)
Come to think of it, it's odd that it's taken Target so long to muster up a response to a competitor's efforts to blatantly siphon off business. One analyst offered this apt comparison to the New York Times:
Now that retailers like Target are aware of this so-called showrooming, carrying Amazon's Kindle is a little "like Starbucks selling Dunkin' Donuts gift certificates," said Michael Norris, a senior analyst for Simba Information.
Earlier this week, an internal Target memo regarding a stopped of Kindle sales was leaked to The Verge, and a Target spokesperson told the site that a vague "conflict of interest" was the reason why.
(MORE: Cheap Eats: Surprising Advice on Dining Out — From an Economist)
Beyond showrooming, another conflict of interest seems to be that Target is in the process of opening Apple mini-stores within 25 existing Target locations. The Apple mini-stores will be selling the full range of Apple products, including the iPad, the world's best-selling tablet—and an obvious competitor of the Kindle. Target will also continue selling the Nook, made by another major Amazon competitor, Barnes & Noble.
Brad Tuttle is a reporter at TIME. Find him on Twitter at @bradrtuttle. You can also continue the discussion on TIME's Facebook page and on Twitter at @TIME.


text:
EU edges to economic sanctions on Russia but narrows scope
The European Union reached outline agreement on Friday
Brussels: The European Union reached outline agreement on Friday to impose the first economic sanctions on Russia over its behaviour in Ukraine but scaled back their scope to exclude technology for the crucial gas sector.
The EU also imposed travel bans and asset freezes on the chiefs of Russia's FSB security service and foreign intelligence service and a number of other top Russian officials, saying they had helped shape Russian government policy that threatened Ukraine's sovereignty and national integrity.
FSB director Alexander Bortnikov and Mikhail Fradkov, a former prime minister who now heads the foreign intelligence service, were among 15 Russians or Ukrainians and 18 companies and other organisations named in the EU's latest sanctions list.
Also sanctioned were the secretary of Russia's Security Council, Nikolai Patrushev, Chechen leader Ramzan Kadyrov, who the EU said had made statements supporting Russia's annexation of Ukraine's Crimea region and the insurgency in eastern Ukraine, and several Ukrainian separatist leaders.
After months of hesitation, the EU is set to go beyond asset freezes by imposing sanctions on sectors of the Russian economy.
The 28-nation EU toughened its stance towards Moscow following last week's downing of a Malaysian airliner, killing 298 people, in an area of eastern Ukraine held by Russian-backed separatists.
EU ambassadors reached a preliminary agreement on Friday.
European Council President Herman Van Rompuy wrote to EU leaders asking them to authorise their ambassadors to complete an agreement by Tuesday. That would avoid the need for leaders to hold a special summit to approve the sanctions.
Van Rompuy said the proposed sanctions package "strikes the right balance" in terms of costs and benefits to the EU and in its flexibility to ramp up sanctions or reverse them over time.
"It should have a strong impact on Russia's economy while keeping a moderate effect on EU economies," he wrote in the letter, seen by Reuters.
But Van Rompuy said the sanctions on access to capital markets, arms and hi-tech goods were likely to apply only to future contracts, leaving France free to go ahead with the controversial delivery of Mistral helicopter carriers being built for Russia.
The narrowing of the proposed measures highlighted the difficulty of agreeing to tough sanctions among countries which have widely different economic interests and rely to varying degrees on Russian gas.
European Commission President Jose Manuel Barroso said late on Friday that following the ambassador's discussions the Commission had adopted a draft legal text for the Russia sanctions package.
"The final decision now lies with the EU's member states, but I believe that this is an effective, well-targeted and balanced package providing the flexibility to adjust our reaction to changes on the ground. I hope that member states will agree on this package of restrictive measures next week," he said in a statement.
The measures are not an end in themselves, "but a means to achieve a negotiated and political solution to the crisis ... I call on Russia to take decisive steps to stop the violence and genuinely engage in peace plan discussions," he said.
EU ambassadors will try to reach a final deal at a meeting on Tuesday.
Key measures include closing EU capital markets to state-owned Russian banks, an embargo on arms sales to Moscow and restrictions on the supply of dual-use and energy technologies. They would not affect current supplies of oil, gas and other commodities from Russia.
Van Rompuy said there was an "emerging consensus" among EU governments that "the measures in the field of sensitive technologies will only affect the oil sector in view of the need to preserve EU energy security."
The Commission had proposed restricting equipment for deep-sea drilling, shale oil and Arctic energy exploration.
If the sanctions had applied to gas technology, they could have affected Gazprom's huge South Stream pipeline project to Europe and Novatek's Arctic Yamal liquefied natural gas (LNG) facility.
That in turn would have hit large EU energy suppliers and manufacturers with an interest in the project, including in Germany, Austria and Italy. The prospect of EU sanctions sent shares in French energy services firm Technip plunging 8 percent on Thursday.
Gazprom's main partners in South Stream are Italy's Eni, France's EDF, Austria's OMV and Germany's Wintershall, a subsidiary of German chemical giant BASF.
Van Rompuy said EU governments also agreed that the sanctions should not be applied retroactively, particularly in the area of arms trade and restrictions on access to capital markets.
France was determined to uphold existing contracts with Russia to preserve a 1.2 billion euro ($1.6 billion) 2011 deal to supply two Mistral helicopter carriers.
EU governments also agreed that a ban on exports of dual-use technology - that can be used in both military and civilian products - would be limited at this stage to military users, Van Rompuy said.
The EU's latest list brought the number of people under EU sanctions to 87 and the number of companies and other organisations to 20.
A further sanctions list could be agreed as early as Monday under new criteria targeting companies and people who support Russian decision-makers responsible for annexing Crimea or destabilising eastern Ukraine, Van Rompuy said. New restrictions on trade and investment in Crimea could also be agreed on Monday, he said.
Dutch Prime Minister Mark Rutte, whose country is seen as having a key role in shaping the EU response because it lost 194 citizens in the plane crash, said he would back sanctions unless Moscow halts weapons supplies to the rebels.
"We want as a country that has acquired a certain moral obligation as a result of this tragedy to promote Europe taking a common line on this," he told parliament in The Hague.
(1 = 0.7436 euros)
( Source : reuters )
Next Story


text:
I'm not especially impressed with most PCs, but one that caught my eye recently was the multimode Lenovo Yoga 2 Pro. Aside from an ultra slim design and gorgeous screen, its main selling point is its multiple orientations – there's a tent mode, a tablet-like flat mode, a stand mode and a laptop mode, all in one device.
Today, Lenovo announced two new additions to its Yoga line: the new 8- and 10-inch Android Yoga Tablet. Like its laptop cousin, the Yoga Tablet is a multimode device that centers around a cylindrical handle and built-in stand. There's a self-explanatory hold mode, a stand mode that keeps your device propped at a 110- to 135-degree angle and a tilt mode that lets you maintain a slight angle when laying the tablet on a table.
The cylindrical handle isn't just for adjusting the device's position – it houses a massive 9,000mAh battery that gives the tablet up to 18 hours of battery life. The battery is so powerful, in fact, that the Yoga is capable of charging your smartphone on-the-go via a micro USB port.
Both models feature Android 4.2 Jelly Bean, a MediaTek quad-core processor, 16GB of expandable storage, 1280 x 800 displays, Dolby audio, a 5MP rear camera and a 1.6MP front-facing one. They're also rather lightweight: The 8-inch version weighs 0.88 pounds, while the larger 10-inch tablet comes in at 1.33 pounds.
The 8-inch Lenovo Yoga Tablet will be available exclusively at Best Buy and through Lenovo starting October 30 with an MSRP of $249. The larger 10-inch device will be available October 30 at most major retailers with an MSRP of $299. To learn more about or purchase the tablets, visit Lenovo.com.


text:
Tuesday, May 25, 2010
Happy Tuesday!
So...today's question of the day has to do with a term I heard on the radio this morning. The morning talent on Hot 97 did an interview with T.I., and one thing that struck me as interesting was T.I. saying he loves a "respectable freak." He took it one step further and said:
"Nobody knows where the nose goes when the do's are closed."
I cracked up!
Now, some would argue that the words "respectable" and "freak" don't go together and shouldn't be used in the same sentence. But some would say that one could be a complete lady (or gentleman) in public while keeping it down and dirty behind closed doors.
So my question to you is: when do you show the freaky side of yourself without being perceived as a ho...or "non-respectable?" Do you bring out the freak right away, or do you keep it under wraps until your "respectable" side has already been established? Are the lines between "slutty" and "freaky" blurry..or are those descriptions totally different?
What say you?
28 comments:
- Annamaria said...
- May 25, 2010 at 12:10 PM
- Anonymous said...
Dammit Annamaria !!!!!!
I have to use ur own taser on u. lolol - May 25, 2010 at 12:11 PM
- Annamaria said...
Like Luda said.. They wanna lady in the streets but a freak in da bed... LMAO
I think respectable & freak go very well together. You want to be the person that helps your mate out. You want to be the partner that they can take to a business dinner. OR the one that they can take to meet momma...
BUT you should also want to be the person that can make their privates tingle at 3:30pm when they are sitting at work & you are no where around them but they just thinking about what happened last night OR what's going to happen that night.
In MY opinion the difference between slutty & freaky are this.. You can be freaky with your MATE OR PARTNER... Slutty is when you are doing ALL those things with whoever you meet.
And no you don't go from 0-freak right away.. It should continue to slip out in spurts as time progresses.... - May 25, 2010 at 12:17 PM
- Yolanda said...
It's absolutely possible to be a respectable freak... the key is how you behave outside of the bedroom. That other 99% of your life is what counts.
I've found most men seem to like the "surprise" actually.
Ok, I'm not talking about sex any more. *depressing*
:-) - May 25, 2010 at 12:17 PM
- Brooke said...
LOL!! Yolanda, you're crazy :)
And you're right - how you conduct yourself outside of the bedroom is what will determine if you're a ho or a "respectable" freak :)
@Annamaria - "privates tingle"? :)
I know that feeling tho...when the thought of someone's touch pops into your head and a chill shoots down your spine...OH YEAH!!! LOL! - May 25, 2010 at 12:22 PM
- A-Buzzzzzz said...
- May 25, 2010 at 12:26 PM
- Stef said...
I think that is a good question. I never quite know when to bring the freak out. I think men like the surprise, but I think it depends on how freaky you get. Normally I just follow his lead, but I find that most men are a bit BEHIND me in the freak dept. Like Chris Rock said, sometimes I have to "ration out the p*ssy" - give it to him in doses so he doesn't think I do certain things all the time. But men tend to give you all their tricks at once. How come we don't think of THEM as freaks OR ho's? Not fair!!!
- May 25, 2010 at 12:33 PM
- Rameer The Circumstance said...
AnnaMaria broke it down so that it need be broken down no further! She hit the nail on the head.
***thinks about what he calls "the spin cycle", shudders and smiles*** - May 25, 2010 at 12:33 PM
- Jay said...
Every man and woman are different. Usually by the time I decide to get intimate with a person, I've already determined if they're a respectable person or not - regardless of what goes down behind closed doors. So to me, if you bring out all your freak the first time we sleep together, I'm not going to look at you any differently than if you ration it out as time goes on. If I think you're a ho, then I will have determined that without having to sleep with you...and no matter how much you "hold on to it", nothing will change that perception. I've slept with women on the first date who I've COMPLETELY respected, and there are women who I didn't have sex with for months who I eventually never respected It's dependent on the person and the circumstances, and if you feel comfortable having sex on the first date and letting your freak loose, how you carry yourself out in public is what I look at. There are some men who judge women based on sex, but I'm not one of them.
- May 25, 2010 at 12:44 PM
- Stef said...
well, I wish more men were like you Jay!
- May 25, 2010 at 12:53 PM
- Anonymous said...
@ Jay if every man were like you there would be a lot less arguing amongst couples.
I agree you can be a respectable freak.if you respect yourself, does it really matter how many partners you have. As I've said in the past these are words/ terminology that is used to shame woman into submission.Words like Ho, Slut, freak ect are used to devalue a woman's sense of sexuality and sexual power.
Everyone has a definition of what a Ho is. I think if you are single and use protection and let your sexual partners know what the deal is a woman can sleep with as many men as she wants and not be Ho. - May 25, 2010 at 1:26 PM
- The Fury said...
Y'all are killing it with this question. I agree all over the place. There's no need in rationing out the freak if you're a respectable person and you know the person respects you. I've seen the most respectful, polished, sometimes prudish acting women in public turn around when the "do' closed" and say and do some wonderfully freaky stuff.
I respected them before and even more after. I mean, how do you hide that toy in that small ass clutch, young lady?? Lmao
Hoes are obvious. They're see through and evident. They're all over the place doing everything everywher.
not to say you have to be silent or hiding to be a respectable freak. You just have to be respectable. Pay your bills, love the world around you, speak with intelligence, have some intelligence, respect your temple...
then let me respect it...over and over again. Lol - May 25, 2010 at 1:38 PM
- Stef said...
Fury with his nasty ass is back :)
Are you blogging for Brooke this TMI Tuesday? (next Tuesday?) - May 25, 2010 at 2:28 PM
- A-buzz said...
WHY DOES STEF KNOW EXACTLY HOW MANY MINUTES THERE ARE TIL TMI TUESDAY/FURY DAY??? lmao
You better watch out for the headboard girl!!!!!!!!!!!! - May 25, 2010 at 2:32 PM
- Stef said...
YOU GOT MAD JOKES A-Buzzz!
I TOLD you, I don't DO doggystyle anymore so my head can't get stuck anymore! LOL!
Fury's TMI Tuesday blogs are always so intriguing! And I can indulge without getting the warning you get when you go to HIS page. (I read his page when I'm at home) :) - May 25, 2010 at 2:55 PM
- A-Buzzzz said...
WHAT I SAID THAT WITH LOVE!!!!!! Just like I am buying you a solid headboard so you don't have to be scared anymore..LMAO
- May 25, 2010 at 2:59 PM
- Stef said...
I'm afraid of banging my head into stuff :) LOL!
- May 25, 2010 at 3:10 PM
- The Cable Guy said...
"Respectable Freaks" don't get their heads stuck in headboards! LMAO!!
- May 25, 2010 at 3:10 PM
- A-BUZZZ said...
Although we cool Captain Cable:
(handing my taser over to Stef) - May 25, 2010 at 3:55 PM
- Stef said...
(taking taser from A-Buzz)
Wasn't nobody talking to YOU Cable Guy...mind ya bidness!
And the MOST RESPECTABLE freaks get their heads stuck and keep it moving! LOL! - May 25, 2010 at 4:00 PM
- Rameer The Circumstance said...
LMFAO @ AnnaMaria and Stef!!!
- May 25, 2010 at 4:25 PM
- The Fury said...
Yes Stef I'll be back. Brooke just gave me the ok for the return and my deadline date. She's one tough cookie, boy I tel ya. Such a respectable....friend. Lmao
hmmmm....Brooke how high does your freak flag fly?
from the looks of it Will Smith has a respectable freak himself... - May 25, 2010 at 4:29 PM
- Jaz said...
I'm actually looking forward to Fury's TMI Tuesday myself :)
- May 25, 2010 at 4:30 PM
- Brooke said...
You have to ask? ;-) - May 25, 2010 at 4:31 PM
- The Fury said...
@Brooke - No I don't have to ask. You can just show me...boy are you lucky I'm bot going to DR....OR maybe I should say unlucky! Lol
- May 25, 2010 at 5:17 PM
- Brooke said...
Yeah, maybe UNlucky :-)
- May 25, 2010 at 5:22 PM
- The Fury said...
gI have to agree with Stef. Only the realest of freaks get their heads stuck in the headboard...but really you can't give up doggystyle because of that experience. You'll lose respect as a freak...not as a person.
- May 25, 2010 at 5:27 PM
- Stef said...
I've been traumatized Fury!!!!
- May 25, 2010 at 5:37 PM


text:
A job search is not a race to find the first job you can get. You have to find the right job for you. At some point, you will need to evaluate a job offer or multiple job offers to decide on your future plans. This is an important decision in both your career and your life. Therefore it should be approached carefully.
It is common practice among many companies to give you a written employment offer. If not, request one. Make sure that the employment offer includes all of the details for the position such as compensation, status, work hours, benefits, and time off. This will help your comparison if you have multiple offers and reduce any misunderstanding on the terms and conditions of your employment.
During the interview process, it's likely that you'll have some discussion of salary. Some companies may ask you to submit your salary history or requirements, while others may informally ask about your expectations. In general, you'll want to be sure you have a good understanding of the position and its responsibilities before you make any commitments about your salary expectations. For this reason, we recommend that you postpone any salary discussions to the later stages of the interview process. If you are asked about salary before you have a clear answer, always give a salary range, not a specific number. Note that it will depend on many factors, including learning more about the responsibilities and expectations of the position as well as the benefits offered.
The offer and negotiation process is different for every job. You should consider the salary and benefits package as a whole. It may not always be appropriate to compare one job against another based on salary alone. You will want to assess what benefits are crucial and which ones you might be able to forego.
Some jobs, like those in unions or government, may have very specific pay grades and benefits packages with very little room for negotiation. Some companies may offer a salary increase after you complete a probationary period and prove yourself.
Before entering a negotiation, you may want to consider the relationship that could result with your potential employer. Remember that while you have the right to refuse an offer, an employer can also withdraw an employment offer.
The best indicator of a successful salary negotiation is that it results in a win-win situation for you and your future employer. It's important that both sides feel like winners and are excited to begin the new relationship.
Job Offer FAQs


text:
| |||||||||
Home Ģ Premium Downloads |
Downloads are available with a premium, ad-free subscription to Modemsite.com. The sign-up is on-line and you can gain access immediately upon completion of your transaction.
Sign up Why sign up?
Log In if you already have a subscription.
Home | Links | Send
Feedback | Privacy Policy | Report Broken Link Legal Page | Author's Web Sites | Log In |
Modemsite.com ®1998-2022 v.Richard Gamberg. All rights reserved. |


text:
Password Reset Enter the email address you registered with us below.If we find an account registered with this address, you'll receive an email message with your username and a link to reset your password within 3 minutes. Reset Password Go back?
Something went wrong That didn't work for some reason . Please try again or get in touch so we can help you out.


text:
Login, Renew or Become a Member of REEA to access exclusive benefits.
*Primary account can manage other accounts. Also, receives all billing and renewal notices
Note: if you are an existing member and wish to renew your membership, please click here to renew.
If you require assistance, please contact Member Care at 520-609-2380 or email@example.com.


text:
Biological Sciences Division
Research Highlights
January 2014
Scientists Capture "Redox Moments" in Living Cells
Better understanding of hardy bacteria enhances tool for biofuel creation
Artistic rendition of cell-permeable chemical probes labeling redox-sensitive cysteine thiols in living Synechococcus sp. PCC7002. The background depicts the photobioreactor used to culture the cyanobacteria. The probes and photobioreactor were developed at Pacific Northwest National Laboratory. Enlarge Image.
Scientists at Pacific Northwest National Laboratory have charted a significant signaling network in a tiny organism that's big in the world of biofuels research. The findings about how a remarkably fast-growing organism conducts its metabolic business bolster scientists' ability to create biofuels using the hardy microbe Synechococcus, which turns sunlight into useful energy.
The team glimpsed key chemical events, known as redox reactions, inside living cells of the organism by using a chemical probe they developed that allows live-cell labeling. They also developed an in vivo labeling and imaging strategy to identify proteins undergoing these reactions in the photoautotrophic cyanobacterium. Their publication in ACS Chemical Biology marks the first time that redox activity, a very fast regulatory network involved in all major aspects of a cell's operation, has been observed in specific proteins within living cells. See more in the PNNL news release.
The research is featured on the journal's cover, and two of the authors, post-bachelor and post-doctoral researchers Natalie Sadler and Dr. Matthew Melnicki, will be profiled on the ACS website as student authors.
Sponsors: U.S. Department of Energy Office of Biological and Environmental Research Genomic Science Program through PNNL's Foundational Sciences Scientific Focus Area (SFA), Biofuels SFA, and Panomics SFA.
Research Team: Natalie C. Sadler, Aaron Wright, Matthew R. Melnicki, Eric D. Merkley, William B. Chrisler, Eric A. Hill, Margaret F. Romine, Sangtae Kim, Erika M. Zink, Suchitra Datta, Richard D. Smith, Alexander S. Beliaev, and Allan Konopka, all PNNL; and Margrethe H. Serres, Marine Biological Laboratory, Woods Hole, Massachusetts.
Research Area: Biological Systems Science
Reference: Sadler NC, MR Melnicki, M Serres, ED Merkley, WB Chrisler, EA Hill, MF Romine, S Kim, EM Zink, S Datta, RD Smith, AS Beliaev, A Konopka, and AT Wright. 2014. "Chemical Profiling of Live Cell Temporal Redox Dynamics in a Photoautotrophic Cyanobacterium." ACS Chemical Biology 9(1). DOI: 10.1021/cb400769v.
Related research: Protein Probes for Biomass


text:
Privacy Notice – How we use pupil information
Why do we collect and use pupil information?
We collect and use pupil information under section 537A of the Education Act 1996, and section 83 of the Children Act 1989. We also comply with Article 6(1)(c) and Article 9(2)(b) of the General Data Protection Regulation (GDPR).
We use the pupil data mainly to support pupil learning and to monitor and report on pupil progress, in addition we use pupil data:
- to provide appropriate pastoral care
- to assess the quality of our services
- to comply with the law regarding data sharing
- to support your child to decide what to do after they leave school
Categories of pupil information that we collect, hold and share include:
Personal information (such as name, unique pupil number and contact details.
- Characteristics (such as ethnicity, language, nationality, country of birth and free school meal eligibility)
- Attendance information (such as sessions attended, number of absences and absence reasons)
- National curriculum assessment results
- Special educational needs information
- Relevant medical information
Collecting pupil information
Whilst the majority of pupil information you provide to us is mandatory, some of it is provided to us on a voluntary basis. In order to comply with the General Data Protection Regulation, we will inform you whether you are required to provide certain pupil information to us or if you have a choice in this.
Storing pupil information
The Federation keeps information about your child on computer systems and also sometimes on paper.
We hold your education records securely until your child changes school. The records will then be transferred to the new school, where they will be retained until they reach the age of 25, after which they are safely destroyed.
There are strict controls on who can see your information. We will not share your data if you have advised us that you do not want it shared unless it is the only way we can make sure your child stays safe and healthy or we are legally required to do so.
Who do we share pupil information with?
We routinely share pupil information with:
- schools or colleges that the pupils attend after leaving us
- our local authority (Kent County Council) and their commissioned providers of local authority services
- the Department for Education (DfE
Why we share pupil information
We do not share information about our pupils with anyone without consent unless the law and our policies allow us to do so.
We share pupils' data with the Department for Education (DfE) on a statutory basis. This data sharing underpins school funding and educational attainment policy and monitoring. To find out more about the data collection requirements placed on us by the DfE (for example; via the school census) go to https://www.gov.uk/education/data-collection-and-censuses-for-schools
We are required to share information about our pupils with our local authority (LA) and the Department for Education (DfE) under section 3 of The Education (Information About Individual Pupils) (England) Regulations 2013.
The National Pupil Database (NPD)
The NPD is owned and managed by the Department for Education and contains information about pupils in schools in England. It provides invaluable evidence on educational performance to inform independent research, as well as studies commissioned by the Department. It is held in electronic format for statistical purposes. This information is securely collected from a range of sources including schools, local authorities and awarding bodies. We are required by law, to provide information about our pupils to the DfE as part of statutory data collections such as the school census and early years' census. Some of this information is then stored in the NPD. The law that allows this is the Education (Information About Individual Pupils) (England) Regulations 2013.
To find out more about the pupil information we share with the department, for the purpose of data collections, go to https://www.gov.uk/education/data-collection-and-censuses-for-schools.
To find out more about the NPD, go to https://www.gov.uk/government/publications/national-pupil-database-user-guide-and-supporting-information.
The department may share information about our pupils from the NPD with third parties who promote the education or well-being of children in England by:
- conducting research or analysis
- producing statistics
- providing information, advice or guidance
The Department has robust processes in place to ensure the confidentiality of our data is maintained and there are stringent controls in place regarding access and use of the data. Decisions on whether DfE releases data to third parties are subject to a strict approval process and based on a detailed assessment of:
- who is requesting the data
- the purpose for which it is required
- the level and sensitivity of data requested: and
- the arrangements in place to store and handle the data
To be granted access to pupil information, organisations must comply with strict terms and conditions covering the confidentiality and handling of the data, security arrangements and retention and use of the data. For more information about the department's data sharing process, please visit:
For information about which organisations the department has provided pupil information, (and for which project), please visit the following website: https://www.gov.uk/government/publications/national-pupil-database-requests-received
Requesting access to your personal data
Under data protection legislation, parents and pupils have the right to request access to information about them that we hold. To make a request for your personal information, or be given access to your child's educational record, contact the school secretary or business manager.
You also have the right to:
- object to processing of personal data that is likely to cause, or is causing, damage or distress
- prevent processing for the purpose of direct marketing
- object to decisions being taken by automated means
- in certain circumstances, have inaccurate personal data rectified, blocked, erased or destroyed; and
- claim compensation for damages caused by a breach of the Data Protection regulations
If you have a concern about the way we are collecting or using your personal data, you should raise your concern with us in the first instance or directly to the Information Commissioner's Office at https://ico.org.uk/concerns/
If you would like to get a copy of the information about you that KCC shares with the DfE or post-16 providers or how they use your information, please contact:
Information Resilience & Transparency Team
Room 2.71
Sessions House
Maidstone, Kent
Email: email@example.com
You can also visit the KCC website if you need more information about how KCC use and store your information. Please go to: http://www.kent.gov.uk/about-the-council/contact-us/access-to-information/your-personal-information
To contact DfE: https://www.gov.uk/contact-dfe
If you would like to discuss anything in this privacy notice, please contact the school office in the first instance.


text:
Reference List
Below you can find all the sources used for our Questions and Answers section. By exploring these sources, you can find the scientific studies and articles that further explain and support the information and services that we provide at Women on Web
Important articles, books and documents:
- WHO recommendations on self-care interventions: self-management of medical abortion
- Coronavirus (COVID-19) infection and abortion care
- Telemedicine for medical abortion: a systematic review
- Clinical follow-up compared with self-assessment of outcome after medical abortion: a multicentre, non-inferiority, randomised, controlled trial. Oppegaard KS1, Qvigstad E2, Fiala C3, Heikinheimo O4, Benson L5, Gemzell-Danielsson K6. Lancet. 2015 Feb 21;385(9969):698-704
- John Riddle. Contraception and Abortion from the ancient world to the renaissance. Harvard University Press 1994.
- Gilda Sedgh et al. Induced abortion: incidence and trends worldwide from 1995 to 2008. The lancet Volume 379, Issue 9816, 18–24 February 2012. Pages 625–632.
- World Health Organization. Safe abortion: technical and policy guidance for health systems (2012). Second edition.
- Preventable maternal mortality and morbidity and human rights. Human Rights Council Eleventh Session Resolution 11/8
- World abortion laws
- von Hertzen H et al. Efficacy of two intervals and two routes of administration of misoprostol for termination of early pregnancy: a randomised controlled equivalence trial. The Lancet. 2007 Jun 9;369(9577):1938-46.
- Kulier R. Medical methods for first trimester abortion. Cochrane Database Syst Rev. 2011 Nov 9;(11):CD002855.
- Nanda K et al. Expectant care versus surgical treatment for miscarriage. Cochrane Database Syst Rev. 2012 Mar 14;3:CD003518
- Gomperts RJ et al. Using telemedicine for termination of pregnancy with mifepristone and misoprostol in settings where there is no access to safe services. BJOG. 2008 Aug;115(9):1171-5; discussion 1175-8.
- Gomperts R et al. Regional differences in surgical intervention following medical termination of pregnancy provided by telemedicine. Acta Obstet Gynecol Scand. 2012 Feb;91(2):226-31.
- Gomperts R et al. Provision of medical abortion using telemedicine in Brazil. Contraception. 2013 Nov 12.
- The General Comment of the Committee on Economic Social and Cultural Rights on the right to the highest attainable standard of health in the International Covenant on Economic, Social and Cultural Rights at paragraph 42 states: "While only States are parties to the Covenant and thus ultimately accountable for compliance with it, all members of society - individuals, including health professionals, families, local communities, intergovernmental and non-governmental organizations, civil society organizations, as well as the private business sector - have responsibilities regarding the realization of the right to health. State parties should therefore provide an environment which facilitates the discharge of these responsibilities.
Reference List Q and A
1. Grossman,|Daniel, Charlotte Ellertson, David A. Grimes and Dilys Walker. (2004) Routine Follow-up Visits After First-Trimester Induced Abortion. .Obstetrics and Gynecology (103)4:738-745
2. Ellertson, Charlotte, Batya Elul, Shuha Ambardekar, Lindy Wood, Julie Carroll and Kurus Coyaji. (2000) Accuracy of assessment of pregnancy duration by women seeking early abortions. Lancet 355: 877-881.
3. Taylor, Diana, Ann C. Hwang and Felicia H. Stewart. (2004) Care for Women Choosing Medication Abortion. The Nurse Practitioner 29(10):65-70.
4. International Consortium for Medical Abortion. (2004) Medical Abortion: Expanding Access to Safe Abortion and Saving Women's Lives. Statement from: Medical Abortion: An International Forum on Policies, Programmes and Services, 17-20 October 2004, Johannesburg, South Africa. Medical Abortion Consortium (Retrieved July 26, 2005)
5. Elul, Batya, Selma Hajri, Nguyen thi Nhu Ngoc, Charlotte Ellertson, Claude Ben Slama, Elizabeth Pearlman and Beverly Winikoff. (2001) Can women in less-developed countries use a simplified medical abortion regimen? Lancet 357:1402-05.
6. The Population Council. (1998) Medical Methods of Early Abortion in Developing Countries: Consensus Statement. Contraception 58:257-59.
7. Harper, Cynthia, Charlotte Ellertson and Beverly Winikoff. (2002) Could American women use mifepristone-misoprostol pills safely with less medical supervision? Contraception 65:133-142.
8. Ashok, P.W., A. Templeton, P.T. Wagaarachchi and G.M.M. Flett. (2004) Midtrimester medical termination of pregnancy: a review of 1002 consecutive cases. Contraception 69:51-8.
9. Grimes, David A. (2005) Risks of Mifepristone Abortion in Context. Contraception 71.
10. E.C.H. Sorensen et al. (2005) Failed Medical Termination of Twin Pregnancy with Mifepristone: A Case Report. Contraception 71:231-233.
11. Wiebe, Ellen, Edith Guilbert, Francis Jacot, Caitlin Shannon and Beverly Winikoff. (2004) A Fatal Case of Clostridium sordellii Septic Shock Syndrome Associated With Medical Abortion. Obstetrics and Gynecology 104(5):1142-44.
12. Monday, July 18, 2005 7:38:39 PM ET, Abortion pill maker alerts doctors to five deaths. Reuters, Washington. Retrieved July 19, 2005.
13. Basu, Ranjan, Tina Gundlach, and Margaret Tasker. (2003) Mifepristone and misoprostol for medical termination of pregnancy: the effectiveness of a flexible regimen. Journal of Family Planning and Reproductive Health Care 29(3):139-41.
14. Stubblefield, Phillip G., Sacheen Carr-Ellis, and Lynn Borgatta. (2004) Methods for Induced Abortion. Obstetrics and Gynecology 104(1): 174-185.
15. Hausknecht, R. (2003) Mifepristone and misoprostol for early medical abortion: 18 months experience in the United States. Contraception 61:463-65.
16. Allen, Rebecca H., Carolyn Westhoff, Lara De Nonno, Stephen L. Fielding, and Eric A. Schaff. (2001) Curettage After Mifepristone-Induced Abortion: Frequency, Timing, and Indications. Obstetrics and Gynecology 98(1): 101-6.
17. Hamoda, Haitham, Premila W. Ashok, Gillian M. M. Flett and Allan Templeton. (2003) Medical abortion at 64 to 91 days of gestation: A review of 483 consecutive cases. American Journal of Obstetrics and Gynecology 188(5): 1315-19.
18. Mitka, Mike. (2000) Some Men Who Take Viagra Die ? Why? Journal of the American Medical Association (283)5: 590-593.
19. Monday, July 19, 2005, 2 More Women Die After Abortion Pills, Gardiner Harris. New York Times Retrieved July 20, 2005.
20. Hamoda, Haitham, Premila W. Ashok, Gillian M.M. Flett, and Allan Templeton. (2005) Medical abortion at 9-13 weeks gestation: a review of 1076 consecutive cases. Contraception 71: 327-332.
21. Ashok, Premila W., Avril Kidd, Gillian M.M. Flett, Ann Fitzmaurice, Wendy Graham and Allan Templeton. (2002) A randomized comparison of medical abortion and surgical vacuum aspiration at 10-13 weeks gestation. Human Reproduction (17)1: 92-98.
22. Ashok, Premila W., Allan Templeton, Prabhath T. Wagaarachchi, and Gillian M.M. Flett. (2002) Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases. British Journal of Obstetrics and Gynaecology 109: 1281-1289.
23. Chen, Aimin, Wei Yuan, Olav Meirik, Xianmi Wang, Shi-Zong Wu, Lifeng Zhou, Lin Lou, Ersheng Gao and Yimin Cheng. (2004) Mifepristone-induced Early Abortion and Outcome of Subsequent Wanted Pregnancy. American Journal of Epidemiology (160)2: 110-117.
24. Coyaji, Kurus, Batya Elul, Usha Krishna, Suhas Otiv, Shubha Ambardekar, Arti Bopardikar, Veena Raote, Charlotte Ellertson and Beverly Winikoff. (2001) Mifepristone abortion outside the urban research hospital setting in India. Lancet 357: 120-21.
25. MedlinePlus Medical Encyclopedia, Ectopic pregnancy
26. Kruse, Beth, Suzanne Poppema, Mitchell D. Creinin and Maureen Paul. (2000) Management of side effects and complications in medical abortion. American Journal of Obstetrics and Gynecology 183(2):S65-S75.
27. American College of Obstetricians and Gynecologists. (1999) The Rh Factor: How It Can Affect Your Pregnancy. Medem Network: Medical Library.
28. Schaff, E.A., S.L. Fielding, S.H. Eisinger et al. (2000) Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days. Contraception 61:41-46.
29. Rossi, Brooke, Mitchell D. Creinin and Leslie A. Meyn. (2004) Ability of the clinician and patient to predict the outcome of mifepristone and misoprostol medical abortion. Contraception 70:313-17.
30. Grimes, David A. and Mitchell D. Creinin. (2004) Induced Abortion: An Overview for Internists. Annals of Internal Medicine 140(8):620-27.
31. Rayas, Luca, Diane Catotti and Ana Corts. (2004) Achieving ICPD commitments for abortion care in Latin America: The unfinished agenda. Ipas: Chapel Hill, NC. IPAS
32. Allan Guttmacher Institute. (1999) Sharing Responsibility: Women, Society and Abortion Worldwide. Alllan Guttmacher Institute
33. Shannon, C., L. Perry Brothers, Neena M. Philip, and Beverly Winikoff. (2004) Infection after medical ab
ortion: a review of the literature. Contraception 70:183-190.
34. Shannon, C., L. P. Brothers, N. Philip and B. Winikoff. (2004) Ectopic Pregnancy and Medical Abortion. Obstetrics and Gynecology. 104(1):161-167.
35. Saraiya M, Green CA, Berg CJ, Hopkins FW, Koonin LM, Atrash HK. (1999) Spontaneous abortion-related deaths among women in the United States ? 1981-1991. Obstetrics and Gynecology 94(2):172-6.
36. Centers for Disease Control and Prevention. (2005) Clostridium sordellii Toxic Shock Syndrome After Medical Abortion with Mifepristone and Intravaginal Misoprostol United States and Canada, 2001 2005. Morbidity and Mortality Weekly Report 54(29):724.
37. U.S. Food and Drug Administration. (2005) FDA Public Health Advisory: Sepsis and Medical Abortion. FDA Retrieved August 5, 2005.
38. Berg, Cynthia J., Jeani Chang, William M. Callaghan, and Sara J. Whitehead. (2003) Pregnancy-Related Mortality in the United States, 1991 1997. Obstetrics and Gynecology 101(2):289-296.
39. McGregor JA, Soper DE, Lovell G, Todd JK. (1989) Maternal deaths associated with Clostridium sordellii infection. American Journal of Obstetrics and Gynecology 161(4):987-95.
40. Creinin, Mitchel D, Eliane Shore, Shyamala Balasubramanian and Bryna Harwood. (2005) The true cost differential between mifepristone and misoprostol and misoprostol-alone regimens for medical abortion.
Contraception 71:26-30.
41. World Health Organization. WHO Mortality Database.
42. Creinin MD, Aubeny E. (1999) Medical Abortion in early pregnancy. In: A Clinician's Guide to Medical and Surgical Abortion, Paul M, Lichtenberg ES, Borgatta L, Grimes DA and Stubblefield PG, eds. Churchill Livingstone: New York.
43. World Health Organization. (2005) The World Health Report 2005 Make Every Mother and Child Count. The World Health Organization: Geneva.WHO
44. Daulaire, Nils, Pat Leidl, Laurel Mackin, Colleen Murphy, and Laura Stark. (2002) Promises to Keep: The Toll of Unintended Pregnancies on Women?s Lives in the Developing World. Global Health Council: Washington, D.C.
45. Rozenberg P, Chevret S, Camus E, Tayrac R, Garbin O, Poncheville L, Coiffic J, Lucot JP, Le Gouell F, Tardif D, Allouche C, Fernandez H, and GROG. (2003) Medical treatment of ectopic pregnancies: a randomized clinical trial comparing methotrexate-mifepristone and methotreate-placebo. Human Reproduction 18(9):1802-08.
46. Gray, Richard. Doctors let 50 women abort babies at home. Scotland on Sunday. July 3, 2005:10
48. G Blanch, Squenbyh, ES Ballantyne, CM Gosden, JP Neilson, K Holland, Embryonic abnormalities at medical termination of pregnancy with Mifepristone and Misoprostol during first trimester. British Medical Journal Vol. 316, pp 1712-1713, 6 June 1998
49. A Pastuszak, L Schuler ea, Use of Misoprostol during pregnancy and Mobius syndrome in infants. The New England Journal of Medicine, Vol. 338, number 26 pp 1881-1885, June 25, 1998
50. L Schuler, A Pastuszak, M Teresa ea. Pregnancy Outcome after exposure to misoprostol in Brazil, a prospective controlled study. Reproductive Toxicology, Vol 13, No 2, pp 147-151, 1999
51. T da Silva Dal Pizzol, V Tierling, ea. Reproductive results associated with Misoprostol and other substances utilized for interruption of pregnancy. Eur.J Clin. Pharmacol (2005) 61: 71-72.
52. David S. Newberger, M.D. Down syndrome: Prenatal risk assessment and diagnosis. American Family Physician, Vol. 62/No. 4 (August 15, 2000)
53. Essential medicines, WHO Model list (revised March 2005), page 20. WHO
54. Hamoda, Ashok, Flett and Templeton. A randomized trial of mifepriston in combination with misoprostol administered sublingually or vaginally for medical abortion at 13-20 weeks of gestation. Human Reproduction. Advance Access, May 5, 2005, pp 1-7.
55. Hedley, Ellertson, Trussell ed, Accounting for time: Insights from a life-table analysis of the efficacy of medical abortion. American Journal of Obstetrics and Gyneacology (2004) 191, pp 1928-33
56. Timothy Craig, Cathy Mende. Common allergic and allergic-like reactions to medications. Postgraduate Medicine, vol105/ no 3/ March 1999
58. G William Palmer, Stephen Dreskin, Anaphylaxis. E-Medicine, October 2004. pp 3. Retrieved August 12, 2005
59. Hamoda, Ashok, Flett, Templeton, A randomized controlled trial of Mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation. BJOG 2005 Aug; 112(8): 1102-8
61. Middleton T, Schaff EA, Fielding SL, Scahill M, Shannon C, Westheimer E, Wilkinson T, Winikoff B. Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of LMP. Contraception 2005; 72:328-332.
62. Hannafin B, Lovecchio F, Do Rh-negative women with first trimester spontaneous abortions need Rh immune globulin? Am J Emerg Med. 2006 Jul;24(4):487-9.
63. "Frequently asked clinical questions about medical abortion", WHO
64. How much supervision is necessary for women taking mifepristone and misoprostol for early medical abortion? Caitlin Shannon1 & Beverly Winikoff, Women's Health, March 2008, Vol. 4, No. 2, Pages 107-111
65. Early abortion pill information
66. Repeat Abortion in the United States Jones RK, Singh S, Finer LB, Frohwirth LF, Occasional Report No. 29, November 2006, p.13
67. Winer N, Resche-Rigon M, Morin C, Ville Y, Rozenberg P., Is induced abortion with misoprostol a risk factor for late abortion or preterm delivery in subsequent pregnancies?, Eur J Obstet Gynecol Reprod Biol. 2009 May 6.
68. Pauleta JR, Clode N, Graça LM, Expectant management of incomplete abortion in the first trimester, Int J Gynaecol Obstet. 2009 Mar 28.
69. Rachael L. McEwing, Nigel G. Anderson, Jeremy B. A. Meates, Richard B. Allen, Greg T. M. Phillipson, and J. Elisabeth Wells. Sonographic Appearances of the Endometrium After Termination of Pregnancy in Asymptomatic Versus Symptomatic Women JUM May 2009 28:579-586
70. Gynuity (2009) Providing medical abortion in low-resource settings: An Introductory Guidebook, Second Edition
71. Bar-Hava I, Aschkenazi S, Orvieto R, et al. Spectrum of normal intrauterine cavity sonographic findings after first trimester abortion. J Ultrasound Med 2001; 20:1277– 1281.
72. Sawyer E, Ofuasia E, Ofili-Yebovi D, Helmy S, Gonzalez J, Jurkovic D. The value of measuring endometrial thickness and volume on transvaginal ultrasound scan for the diagnosis of incomplete miscarriage. Ultrasound Obstet Gynecol 2007; 29:205–209
73. Akin A., Blum J., Özalp S., Onderoglu L., Kirca U., Bilgili N, et al. (2004); Results and lessons learned from a small medical abortion clinical study in Turkey. Contraception; 70; 401 – 406
74. Bracken H. (2010); Home administration of misoprostol for early medical abortion in India. International Journal of Gynecology and Obstetrics; 108; 228 – 232
75. Chuni N., Chandrashekhar TS. (2009) Early pregnancy termination with a simplified mifepristone: Medical abortion outpatient regimen. Kathmandu University Medical Journal; 7 (3) Issue 27; 209 – 212
76. Creinin M.D., Pymar H.C., Schwartz J.L. (2001); Mifepristone 100 mg in abortion regimens. Obstetrics & Gynecology; 98 (3); 434 – 439
77. Creinin M.D., Schreiber C.A., Bednarek P., Lintu H., Wagner M.S., Meyn L.A. (2007) Mifepristone and Misoprostol Administered Simultaneously Versus 24 Hours Apart for Abortion: A Randomized Controlled Trial. Obstetrics & Gynecology; 109 (4); 885–94
78. Fjerstad M., Sivin I., Lichtenberg E.S., Trussell J., Cleland K., Cullins V. (2009) Effectiveness of medical abortion with mifepristone and buccal misoprostol through 59 gestational days. Contraception; 80; 282 – 286
79. Guest J., Chien P., Thomson M., Kosseim M. (2007) Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol. BJOG; 114; 207 – 215
80. Heikinheimo O., Gissler M., Suhonen S. (2008). Age, parity, history of abortion and contraceptive choices affect the risk of repeat abortion. Contraception; 78; 149 – 154
81. Henderson J.T., Hwang A.C., Harper C.C., Stewart F.H. (2005) Safety of mifepristone abortions in clinical use; Contraception. 72; 175 – 178
82. von Hertzen H., Piaggio G., Wojdyla D., Marions L., My Huong N.T., Tang O.S. et al. (2009) Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial. The World Health Organization Journal compilation. BJOG An International Journal of Obstetrics and Gynaecology Feb;116(3):381-9.
83. Kopp Kallner H., Fiala C., Stephansson O., Gemzell-Danielsson K. (2010) Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days. Hum Reprod. 2010 May;25(5):1153-7
84. Knudsen U.B. (2001) First trimester abortion with mifepristone and vaginal Misoprostol. Contraception; 63; 247 – 250
85. Li Y.T., Hou G.Q., Chen T.H., Chu Y.C., Lin T.C., Kuan L.C., et al. (2008) High-Dose Misoprostol as An Alternative Therapy After Failed Medical Abortion. Taiwan Journal of Obstetrics and Gynecology; 47 (4); 408 – 411
86. Lin M., Li Y.T., Chen F.M, Wu S.H., Tsai C.W., Chen T.A., et al. (2006); Use of Mifepristone and Sublingual Misoprostol for Early Medical Abortion. Taiwanese Journal of Obstetrics and Gynecology; 45 (4); 321 – 324
87. Livshits A., Machtinger R., David L.B., Spira M., Moshe-Zahav A., Seidman D.S. (2009) Ibuprofen and paracetamol for pain relief during medical abortion: a double-blind randomized controlled study. Fertility and Sterility; 91 (5); 1877 – 1880
88. Manaktala U., Singla R., Rathore A.M., Garg S. (2007) Low Dose Mifepristone And Vaginal Misoprostol: A Safe Option For Termination Of Pregnancy Up To 63 Days. The Internet Journal of Gynecology and Obstetrics; 8 (1)
89. Middleton T., Schaff E., , Fielding S.L., Scahill M., Shannon C., Westheimer E., et al. (2005) Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period. Contraception; 72; 328– 332
90. Nobili M.P., Piergrossi S., Brusati V., Moja E.A. (2007) The effect of patient-centered contraceptive counseling in women who undergo a voluntary termination of pregnancy. Patient Education and Counseling; 65; 361–368
91. Perriera L.K., Reeves M.F., Chena B.A., Hohmanna H.L., Hayesa J., Creinin M.D. (2010) Feasibility of telephone follow-up after medical abortion. Contraception; 81; 143–149
92. Raghavan S., Comendant R., Digol I., Ungureanu S., Friptu V, Bracken H., et al. (2009) Two-pill regimens of misoprostol after mifepristone medical abortion through 63 days' gestational age: a randomized controlled trial of sublingual and oral Misoprostol. Contraception; 79; 84 – 90
93. Raghavan S., Comendant R., Digol I., Ungureanu S., Dondiuc I., Turcanu S., et al. (2010); Comparison of 400 mcg buccal and 400 mcg sublingual misoprostol after mifepristone medical abortion through 63 days' LMP: a randomized controlled trial. Contraception,Dec 82(6):513-9
94. Reeves M.F., Kudva A., Creinin M.D. (2008) Medical abortion outcomes after a second dose of misoprostol for persistent gestational sac. Contraception; 79; 332 – 335
95. Schaff E.A., Fielding S.L., Westhoff C. (2002) Randomized trial of oral versus vaginal Misoprostol 2 days after mifepristone 200 mg for abortion up to 63 days of pregnancy. Contraception; 66; 247 – 250
96. Schaff E.A., Fielding S.L., Westhoff C., Ellertson C, Eisinger S.H., Stadalius L.S., et al. (2000) Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion. Journal of the American Medical Association; 284; 1948 – 53
97. Shan Tang O., Chan C.C.W., Ng E.H.Y., Lee S.W.H., Chung Ho P. (2003) A prospective, randomized, placebo‐controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks gestation. Human Reproduction; 18 (11); 2315 – 2318
98. Shannon C., Wiebe E., Jacot F., Guilbert E., Dunn S., Sheldon W.R., et al. (2006) Regimens of misoprostol with mifepristone for early medical abortion: a randomised trial. BJOG An International Journal of Obstetrics and Gynaecology; 133; 621 – 628
99. Shannon C.S., Winikoff B., Hausknecht R., Schaff E., Blumenthal P.D., Oyer D., et. al. (2005) Multicenter Trial of a Simplified Mifepristone Medical Abortion Regimen. Obstetrics & Gynecology; 105 (2); 345 – 351
100. Shuchita M., Shveta K., Batya E., Suresh U. (2008) Simplifying medical abortion: Home administration of Misoprostol. Journal of Obstetrics and Gynecology of India; 58 (5); 410 – 416
101. Winikoff B., Dzuba I.G., Creinin M.D., Crowden W.A., Goldberg A.B., Gonzales J., et al. (2008) Two Distinct Oral Routes of Misoprostol in Mifepristone Medical Abortion: A Randomized Controlled Trial. Obstetrics & Gynecology; 112 (6); 1303 – 1310
102. Wedisinghe, L., Elsandabesee, D. (2010) Flexible mifepristone and misoprostol administration interval for first-trimester medical termination. Contraception, Volume 81, Issue 4, April, Pages 269-274
103. Fiala C, Gemzel-Danielsson K (2006) Review of medical abortion using mifepristone in combination with a prostaglandin analogue. Contraception. 2006 Jul;74(1): 66-86
104. Gemzell-Danielsson K, Lalitkumar S. (2008) Second trimester medical abortion with mifepristone-misoprostol and misoprostol alone: a review of methods and management. Reprod Health Matters May;16(31 Suppl): 162-72
105. Ho PC, Blumenthal PD, Gemzell-Danielsson K, Gómez Ponce de León R, Mittal S, Tang OS. (2007) Misoprostol for the termination of pregnancy with a live fetus at 13 to 26 weeks. Int J Gynaecol Obstet. 2007 Dec;99 Suppl 2: S178-81
106. Anti-D administration after spontaneous miscarriage for preventing Rhesus alloimmunisation., Karanth L1, Jaafar SH, Kanagasabai S, Nair NS, Barua A. Cochrane Database Syst Rev. 2013 Mar 28;3:CD009617. doi: 10.1002/14651858.CD009617.pub2.http://www.ncbi.nlm.nih.gov/pubmed/23543581
107. The accuracy of using last menstrual period to determine gestational age for first trimester medication abortion: a systematic review. Schonberg D1, Wang LF2, Bennett AH3, Gold M2, Jackson E4. Contraception. 2014 Nov;90(5):480-7. doi: 10.1016/
Further Readings
Psychological studies:
Adler NE, David HP, Major BN, Roth SH, Russo NF, Wyatt GE. (1992) Psychological factors in abortion: a review.
American Psychology 47:1194-204.
Dagg PKB. (1991) The psychological sequelae of therapeutic abortion: denied and completed. American Journal of Psychiatry 148:578-85.
Stotland NL. (1997) Psychosocial aspects of induced abortion. Clinical Obstetrics and Gynecology 40:673-86.
Stotland NL. (2002) Psychiatric issues related to infertility, reproductive technologies, and abortion. Primary Care 29:13-26.
AMRC — Academy of Medical Royal Colleges (2011) Induced Abortion and Mental Health: A Systematic Review of the Mental Health Outcomes of Induced Abortion, Including their Prevalence and Associated Factors. London: Academy of Medical Royal Colleges
Charles, Vignetta E., et al. (2008). Abortion and Long-Term Mental Health Outcomes: A Systematic Review of the Literature. Contraception, 78, 436–50
Timing of Misoprostol administration:
Schaff EA, Fielding SL, Westhoff C, et al. Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion. Journal of the American Medical Association 2000;284:1948-53.
Use of mifepristone and misoprostol in nonpregnant women:
Glasier A, Thong M, Dewr M, Mackie M, Baird D. (1992) Mifepristone (RU 486) compared with high-dose estrogen and progestagen for emergency contraception. New England Journal of Medicine 1992; 327:1041-4.
Webb A, Russell J, Elstein M. Comparison of Yuzpe regimen, danazol, and mifepristone (RU 486) in oral postcoital contraception. British Medical Journal 1992; 305:927-31.


text:
Volunteering Opportunities
With many different areas to choose from, you can find a volunteer opportunity that fits your skills and interests. Here are some of the areas of service for auxiliary members at Sutter Amador Hospital:
- Pediatrics
- Radiology
- Concierge cart
- Clerical assistance
- Auxiliary thrift shop
516 Sutter Street
Jackson, CA 95642
Phone: (209) 223-5570
Open Monday through Saturday from 10:00 am to 3:00 pm - Gift shop
- Surgery Department
- Information desk
- Medical/Surgical Department
- Health centers
- Food and Nutrition Service Department
Benefits of Volunteering
"There is no exercise better for the heart than reaching down and lifting people up." — John Andrew Holmes
Volunteering is a wonderful gift that can be given to patients and the community. Volunteers meet people, make new friends, use their skills and acquire new ones. They feel a sense of accomplishment and perhaps the most important benefit is satisfaction of knowing they are contributing to their community and making a difference.
To volunteer at Sutter Amador Hospital, you must apply to become a member of the auxiliary. Applications to join the auxiliary are also available in the hospital lobby. All volunteers must submit an application and complete a drug screen and tuberculosis test. Auxiliary dues are $10 per year.
For information about joining the Sutter Amador Hospital Auxiliary, please call the Gift Shop at (209) 223-7514.


text:
I really want to write, but as soon as I sit down and set pen to paper, my mind goes blank.
I can't think of anything to write. Sometimes I stare at my screen for hours; doesn't help.
If I do think of something, it feels stupid, it won't work, it's cliche, etc. Can someone tell me what to do? Am I too anxious, have too high expectations, or trying to think too hard? I simply cannot write.
How do I get over this? Have other people coped with this problem successfully? How?